After 18 months at the excellent Stevenage Bioscience Catalyst we have moved into a new space on the Cambridge Science Park. We are thrilled to join the amazing scientific ecosystem surrounding Cambridge, and look forward to building relationships with our new industrial and academic neighbours.
Bio-start announced the 15 companies that will be joining the UK’s first synthetic biology accelerator programme. Applicants from across the UK have applied for entry into the 10-week intensive programme of high-quality mentorship, entrepreneurial training & workshops, with access to a global network of customers and opportunities. We are thrilled to be part of this exciting program, and look forward to meeting the other.
We have been selected from a strong panel of ambitious companies to present at Pitchfest 2016 on November 8th. The event is organised by the Enterprise Europe Network, and will be hosted at the St. John's Innovation Centre in Cambridge. You can read more about the event, and the other startups that will be attending, on Business Weekly.
Our CCO Jiahao Huang had the opportunity to present to the minds of the future, when they visited the Stevenage Bioscience Catalyst for a multiday Biomedical workshop. Jiahao also took part in a discussion panel where the audience posed interesting questions about entrepreneurship, such as building the right team and raising funding.
We will be attending Innovate 2016, the flagship event run by InnovateUK. On 2nd-3rd November we will be in Manchester to speak about our technology, and learn about the other exciting innovation happening within the UK.
We have now taken up laboratory space in the Stevenage BioScience Catalyst, and look forward to an exciting 2016 working at these excellent facilities among other entrepreneurial bioscience operations.
01 / 11 / 2015
Nuclera have become virtual tenants at the Stevenage BioScience Catalyst, and will take up physical tenancy in January 2016. This move will place us at the centre of a world-leading life sciences cluster, acclerating our R&D through access to a wide-range of excellent facilities. Furthermore, the campus is an entrepreneurial hub for life sciences in the UK, so provides the ideal environment for Nuclera to grow and forge partnerships, both scientific and commercial, with other parties on the site.
Stevenage BioScience Catalyst is a joint venture between the Department for Business Innovation and Skills, GlaxoSmithKline, the Wellcome Trust and Innovate UK. They aim to give the next generation of pharma and biotech companies access to a spectrum of translation research and development activities and opportunities. This culture of open innovation will accelerate the discovery of cutting-edge healthcare solutions and place the UK bioscience sector at the forefront of worldwide biomedical innovation.
01 / 11 / 2015
We are pleased to relaunch our website, which we hope you will find elegant and informative. The new layout better allows users to learn about Nuclera - the vision, the process and the team. If you have any comments on the new design, or indeed wish to contact us for any other reason, please use the contact form and we will get back in touch soon.